BeOne Medicines (ONC) Minority Interest (2017 - 2020)

BeOne Medicines (ONC) has reported Minority Interest for 4 consecutive years, with $9.1 million the latest figure, recorded in Q3 2020.

• In Q3 2020, Minority Interest fell 42.15% year-over-year to $9.1 million; the TTM figure through Sep 2020 stood at $9.1 million (down 42.15% YoY), while the FY2019 annual figure was $16.2 million, up 11.8% from the prior year.
• Minority Interest slipped to $9.1 million in Q3 2020 per ONC's latest filing, from $10.2 million in the prior quarter.
• Across five years, Minority Interest topped out at $17.4 million in Q2 2019 and bottomed at $9.1 million in Q3 2020.
• Historically, Minority Interest has averaged $14.0 million across 4 years, with a median of $14.4 million in 2017.
• Annual changes were most pronounced in 2019 — Minority Interest gained 29.07% — and 2020, when it sank 42.15%.
• BeOne Medicines' Minority Interest stood at $14.4 million in 2017, then gained by 0.16% to $14.4 million in 2018, then climbed by 11.8% to $16.2 million in 2019, then sank by 43.55% to $9.1 million in 2020.
• Business Quant data shows ONC's Minority Interest at $9.1 million in Q3 2020, $10.2 million in Q2 2020, and $14.8 million in Q1 2020.